Drug Type Small molecule drug |
Synonyms RPR 208707 |
Target |
Action inhibitors |
Mechanism factor Xa inhibitors(Factor Xa inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H17N5O3S2 |
InChIKeyPLXOQMHGHDZMSX-AWEZNQCLSA-N |
CAS Registry209285-84-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Thrombosis | Preclinical | United States | - | |
| Thrombosis | Preclinical | France | - |





